enGene Therapeutics (ENGN) Cash from Investing Activities (2023 - 2026)
enGene Therapeutics' Cash from Investing Activities was $30.12 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with $1.38 million a year earlier and up 27.4% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Cash from Investing Activities (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, enGene Therapeutics' Cash from Investing Activities was -$32.04 million through Jul 31, 2026; for FY2025 (ended Oct 31, 2025), it was -$25.14 million.
- In earlier fiscal years, Cash from Investing Activities was -$125.95 million in FY2024, -$318,000 in FY2023 and -$153,000 in FY2022.
- Quarterly Cash from Investing Activities has moved between -$126.3 million (fiscal Q1 2026) and $40.5 million (fiscal Q4 2025) over five years.
- Per Business Quant data, ENGN's Cash from Investing Activities in the three fiscal quarters before Q3 2026 was $23.64 million (Q2 2026), -$126.3 million (Q1 2026) and $40.5 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | enGene Therapeutics | 130.01 Mn | 130.01 Mn | - | 30.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 30.12 Mn |
| Apr 30, 2026 | 23.64 Mn |
| Jan 31, 2026 | -126.30 Mn |
| Oct 31, 2025 | 40.50 Mn |
| Jul 31, 2025 | 1.38 Mn |
| Apr 30, 2025 | 17.95 Mn |
| Jan 31, 2025 | -84.96 Mn |
| Oct 31, 2024 | -125.27 Mn |
| Jul 31, 2024 | -2,000.00 |
| Apr 30, 2024 | -179,000.00 |
| Jan 31, 2024 | -506,000.00 |
| Oct 31, 2023 | -138,000.00 |
| Jul 31, 2023 | -157,000.00 |
| Apr 30, 2023 | -10,000.00 |
| Jan 31, 2023 | -13,000.00 |
API Access
enGene Therapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();